Schizophrenia, a major psychiatric disorder defined by delusions and hallucinations, among other symptoms, often with onset in early adulthood, is potentially associated with molecular and cellular alterations in parvalbumin-expressing fast spiking interneurons and other constituents of the cortical inhibitory GABAergic circuitry. The underlying mechanisms, including the role of disease-associated risk factors operating in adolescence such as drug abuse and social stressors, remain incompletely understood. Here, we summarize emerging findings from animal models, highlighting the ability of parvalbuminergic interneurons (PVI) to induce, during the juvenile period, long-term plastic changes in prefrontal and visual cortex, thereby altering perception, cognition and behavior in the adult. Of note, molecular alterations in PVI from subjects with schizophrenia, including downregulated expression of a subset of GABAergic genes, have also been found in juvenile stress models of the disorder. Some of the transcriptional alterations observed in schizophrenia postmortem brain could be linked to changes in the epigenetic architecture of GABAergic gene promoters, including dysregulated DNA methylation, histone modification patterns and disruption of promoter-enhancer interactions at site of chromosomal loop formations. Therefore, we predict that, in the not-to-distant future, PVI-and other cell-type specific epigenomic mappings in the animal model and human brain will provide novel insights into the pathophysiology of schizophrenia and related psychotic diseases, including the role of cortical GABAergic circuitry in shaping long-term plasticity and cognitive function of the cerebral cortex.
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Introduction
Schizophrenia (SCZ), a mental disorder associated with delusions, hallucinations, disorganized thought, social withdrawal and various other symptoms is not defined by unifying neuropathology (Catts et al., 2013; Dorph-Petersen & Lewis, 2011) or narrowly defined genetic risk architectures (Andreassen, Thompson, & Dale, 2014; Rodriguez-Murillo, Gogos, & Karayiorgou, 2012) . However, clinical and preclinical research is beginning to identify major building blocks that contribute to the complex pathophysiology of SCZ. One such building block is the GABAergic circuitry in the cerebral cortex. GABAergic interneurons provide a major and critical source of inhibition to cortical networks, as animal models of disrupted GABAergic signaling show deficits in cortical plasticity (Fagiolini et al., 2004; Hensch, 2005; Hensch et al., 1998; Iwai, Fagiolini, Obata, & Hensch, 2003; Katagiri, Fagiolini, & Hensch, 2007) , synchronous oscillations (Gonzalez-Burgos, Fish, & Lewis, 2011; Lodge, Behrens, & Grace, 2009 ) and cognition (GonzalezBurgos et al., 2011; Gruber et al., 2010) . Importantly, similar phenotypes are encountered in SCZ (Gonzalez-Burgos et al., 2011; Inan, Petros, & Anderson, 2013; Lewis, Hashimoto, & Volk, 2005) . GABAergic interneurons, however, are an extremely diverse population that can be molecularly classified into three non-overlapping groups based on the expression of either Parvalbumin (PV), Somatostatin (SST) or serotonin receptor 3a (5-HT 3A R) that together encompass nearly 100% of all cortical interneurons (Rudy, Fishell, Lee, & Hjerling-Leffler, 2011) . Among these subpopulations, fast-spiking interneurons expressing PV provide inhibition
